Multimedia

Leadership Under Threat: Assessing U.S. International Competitiveness in Biomedical Research

May 17, 2012
The U.S. needs to re-examine its competitiveness in the life sciences sector.

ITIF and United for Medical Research release a report benchmarking international competitiveness in biomedical research. The United States’ leadership position in biomedical research is no longer assured, especially as the governments of an increasing number of countries are investing more in life sciences research as a share of their GDP than the United States. This report documents the economic impact of public investment in life sciences R&D, quantifying its impact on innovation, employment, and export levels of the U.S. life sciences industry and analyzes what other competitor nations are doing to support life sciences innovation.

See video